Aging Population And Global Approvals Will Advance Cardiac Devices

Published
28 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$41.69
7.5% overvalued intrinsic discount
15 Aug
US$44.83
Loading
1Y
71.0%
7D
4.7%

Author's Valuation

US$41.7

7.5% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 Aug 25
Fair value Increased 24%

The significant upward revision in Artivion’s consensus price target reflects improved sentiment, underpinned by rising future P/E and net profit margin, resulting in a new fair value estimate of $38.00. What's in the News Raised 2025 revenue guidance to $435–$443 million, with expected constant currency growth of 12% to 14%.